Related Experiment Video
Updated: Aug 17, 2026

The Application Of Permanent Middle Cerebral Artery Ligation in the Mouse
Published on: July 25, 2011
Diagnosis and treatment of cerebral amyloid angiopathy
1Department of Clinical Neurosciences, Brown University, Providence, Rhode Island.
Insights
Cerebral amyloid angiopathy (CAA) involves amyloid buildup in brain vessels, leading to lobar hemorrhages. Diagnosis requires brain biopsy, and management focuses on blood pressure control, avoiding blood thinners.
Area of Science:
- Neurology
- Pathology
- Vascular Biology
Background:
- Cerebral amyloid angiopathy (CAA) is characterized by amyloid deposition in leptomeningeal and cortical vessels.
- It predominantly affects individuals over 60 and is linked to lobar intracerebral hemorrhage, normal aging, Alzheimer's disease, and other cerebrovascular conditions.
- The amyloid deposits in CAA share biochemical similarities with those found in Alzheimer's disease and normal aging.
Purpose of the Study:
- To elucidate the characteristics and clinical manifestations of cerebral amyloid angiopathy (CAA).
- To understand the association of CAA with intracerebral hemorrhage and dementia.
- To outline diagnostic and management strategies for CAA.
Main Methods:
- Review of existing literature on CAA, focusing on its pathology, clinical presentation, and associations.
- Analysis of biochemical studies comparing amyloid deposits in various neurological conditions.
- Discussion of diagnostic methods, including brain biopsy, and current management approaches for CAA-associated hemorrhage.
Main Results:
- CAA primarily manifests as lobar intracerebral hemorrhage, increasing in frequency with age.
- Identical amyloid deposits are observed in CAA, normal aging, Alzheimer's disease, and hereditary cerebral hemorrhage.
- The precise mechanisms linking CAA to hemorrhage and dementia remain incompletely understood.
Conclusions:
- Cerebral amyloid angiopathy is a significant cause of lobar hemorrhage in the elderly.
- Definitive diagnosis of CAA necessitates a brain biopsy.
- Management emphasizes hypertension control and supportive care, with avoidance of antiplatelet/anticoagulant therapies in affected patients.
Abstract:
CAA is the infiltration of leptomeningeal and penetrating cortical vessels with amyloid, sparing the subcortical regions and the systemic vasculature. It occurs with increasing frequency after the sixth decade. The major clinical manifestation of CAA is lobar intracerebral hemorrhage, which can be sporadic or hereditary. CAA has also been associated with normal aging, Alzheimer's disease, cerebral infarction, and periventricular demyelination. Biochemical studies have shown that the amyloid deposits in the brains of patients with normal aging, sporadic CAA-associated hemorrhage, hereditary cerebral hemorrhage, and Alzheimer's disease are identical. The exact mechanism by which CAA produces lobar hemorrhages and the role of CAA in the development of dementia are unclear. Biopsy of the involved cerebral cortex and leptomeninges is the only definitive way to diagnose CAA. Acute management of CAA-associated lobar hemorrhage consists of aggressive control of associated hypertension and supportive care. Surgical removal of the hemorrhage has not been shown to improve survival. Antiplatelet and anticoagulant therapy should be avoided in elderly patients with known CAA.
More Related Videos
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Cerebral Edema ll: Pathophysiology
Dementia l: Introduction
Hepatic Encephalopathy

